DK1131087T4 - Lindring af prostatacancersymptomer - Google Patents

Lindring af prostatacancersymptomer

Info

Publication number
DK1131087T4
DK1131087T4 DK99958892T DK99958892T DK1131087T4 DK 1131087 T4 DK1131087 T4 DK 1131087T4 DK 99958892 T DK99958892 T DK 99958892T DK 99958892 T DK99958892 T DK 99958892T DK 1131087 T4 DK1131087 T4 DK 1131087T4
Authority
DK
Denmark
Prior art keywords
relief
bmp
prostate cancer
cancer symptoms
gdf
Prior art date
Application number
DK99958892T
Other languages
English (en)
Other versions
DK1131087T3 (da
Inventor
Kuber T Sampath
Charles M Cohen
David C Rueger
Original Assignee
Stryker Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22704676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131087(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stryker Corp filed Critical Stryker Corp
Application granted granted Critical
Publication of DK1131087T3 publication Critical patent/DK1131087T3/da
Publication of DK1131087T4 publication Critical patent/DK1131087T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
DK99958892T 1998-11-13 1999-11-12 Lindring af prostatacancersymptomer DK1131087T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19123998A 1998-11-13 1998-11-13
PCT/US1999/026636 WO2000029012A2 (en) 1998-11-13 1999-11-12 Methods of alleviating cancer symptoms

Publications (2)

Publication Number Publication Date
DK1131087T3 DK1131087T3 (da) 2004-12-13
DK1131087T4 true DK1131087T4 (da) 2009-08-03

Family

ID=22704676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99958892T DK1131087T4 (da) 1998-11-13 1999-11-12 Lindring af prostatacancersymptomer

Country Status (10)

Country Link
EP (2) EP1435243A3 (da)
JP (2) JP4892131B2 (da)
AT (1) ATE275416T1 (da)
AU (1) AU1616700A (da)
CA (1) CA2349038C (da)
DE (1) DE69920033T3 (da)
DK (1) DK1131087T4 (da)
ES (1) ES2226467T5 (da)
PT (1) PT1131087E (da)
WO (1) WO2000029012A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
KR101008758B1 (ko) * 2001-09-18 2011-01-14 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
CA2561809A1 (en) * 2004-03-31 2005-10-20 Xencor, Inc. Bmp-7 variants with improved properties
US20100035240A1 (en) * 2004-08-10 2010-02-11 Cardiff Biologicals Limited Methods and kit for the prognosis of breast cancer
WO2006029406A2 (en) * 2004-09-09 2006-03-16 Stryker Corporation Methods for treating bone tumors using bone morphogenic proteins
JP2008169116A (ja) * 2005-04-18 2008-07-24 Tokyo Medical & Dental Univ Ｂｍｐ−７を含む抗ｃ型肝炎ウイルス剤
ATE520711T1 (de) 2005-05-27 2011-09-15 Bbs Bioactive Bone Substitutes Oy Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten
WO2006125866A1 (en) 2005-05-27 2006-11-30 Bbs-Bioactive Bone Substitutes Oy Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
US7910552B2 (en) 2005-05-27 2011-03-22 Bbs-Bioactive Bone Substitutes Oy Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
PL3117833T3 (pl) * 2005-07-19 2019-06-28 Stemgen S.P.A. Hamowanie przez lif zdolności do tworzenia guzów przez komórki macierzyste guza
GB0615129D0 (en) * 2006-07-29 2006-09-06 Univ Cardiff Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399569B1 (en) * 1991-03-11 2002-06-04 Curis, Inc. Morphogen treatments for limiting proliferation of epithelial cells
ES2161693T3 (es) † 1991-03-11 2001-12-16 Curis Inc Morfogenesis inducida por proteinas.
US5652118A (en) † 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US6287816B1 (en) * 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
DK0653942T3 (da) † 1992-07-31 2003-10-20 Curis Inc Morphogen-induceret nerve-regenerering og -reparation
EP0680334B1 (en) * 1992-09-15 2000-12-13 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
DE69535641D1 (de) † 1994-04-29 2007-12-27 Curis Inc Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤
FR2737501B1 (fr) * 1995-07-31 1997-10-24 Transgene Sa Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants
AU7115996A (en) † 1995-09-21 1997-04-09 Trustees Of Columbia University In The City Of New York, The Uses of bone morphogenetic proteins
WO1998050061A1 (en) * 1997-05-07 1998-11-12 Biogen, Inc. Novel therapies for cystic kidney disease

Also Published As

Publication number Publication date
DK1131087T3 (da) 2004-12-13
JP2002529513A (ja) 2002-09-10
WO2000029012A3 (en) 2000-11-16
WO2000029012A8 (en) 2001-01-11
DE69920033T3 (de) 2009-10-08
EP1131087B1 (en) 2004-09-08
EP1435243A2 (en) 2004-07-07
CA2349038A1 (en) 2000-05-25
CA2349038C (en) 2011-08-02
PT1131087E (pt) 2004-12-31
DE69920033T2 (de) 2005-09-22
EP1131087B2 (en) 2009-04-01
EP1435243A3 (en) 2005-02-09
DE69920033D1 (de) 2004-10-14
ES2226467T5 (es) 2009-08-27
EP1131087A2 (en) 2001-09-12
AU1616700A (en) 2000-06-05
JP4892131B2 (ja) 2012-03-07
WO2000029012A2 (en) 2000-05-25
JP2010150278A (ja) 2010-07-08
ES2226467T3 (es) 2005-03-16
ATE275416T1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
Moan et al. The biophysical foundations of photodynamic therapy
DK1131087T4 (da) Lindring af prostatacancersymptomer
SE9900100D0 (sv) New compounds
CY1110570T1 (el) Χρηση της ουριδινης σε συνδυασμο με χολινη για τη θεραπεια διαταραχων της μνημης
CA2170700A1 (en) Pyrazolopyrimidines and Pyrrolopyrimidines for Treatment of Neuronal and Other Disorders
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
AU6613896A (en) Chemical compounds
JP2000503980A5 (da)
DE60107234D1 (de) Antitubulinanordnung und zellenwachstumshemmstoff "dioxostatin"
MXPA02012626A (es) Bis-arilsufonas.
WO2000018439A3 (de) Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren
IT1318667B1 (it) Medicamento antinfiammatorio.
NO20032762L (no) Aktivitetsstyringsanordning
TR199901017A2 (xx) B�cek ilac� terkibi.
WO2002099422A3 (en) Individualization of therapy with alzheimer's disease agents
Font et al. Finding the words: Instruments for a therapy of liberation
EP1328236A4 (en) METHODS OF PREVENTING OR PREVENTING PAIN WITH SPICAMYCIN DERIVATIVES
Coppola et al. Early retroduodenal perforation following endoscopic internal biliary drainage
DE69625210T2 (de) Nicorandil gegen angstneurosen
IT1302188B1 (it) Procedimento e dispositivo atti alla regolazione di una grandezzadi funzionamento di un veicolo.
CA2452432A1 (en) Active ingredient combination for the pharmacological therapy of nicotine dependence
TNSN00247A1 (fr) Combinaison de trimebutine avec un analgesique opioide .
ITBO970709A0 (it) Dispositivo per il comando dall'esterno di una serratura antipanico.
Вінник ÏÐÀÂβ ÇÀÑÎÁÈ ÇÀÕÈÑÒÓ ÏÐÀ ÒÀ ²ÍÒÅÐÅѲ ÀÊÖ²ÎÍÅвÂ
IT1280863B1 (it) Procedimento per produrre una forma attiva di incenso e relativo uso dell'incenso stesso.